26.30 
0.11(0.42%) May 17, 4:01PM EDT
| Prev Close: | 26.19 |
|---|
| Open: | 26.28 |
|---|
| Bid: | 17.61 x 200 |
|---|
| Ask: | 37.93 x 200 |
|---|
| 1y Target Est: | 30.00 |
|---|
| Beta: | 2.2 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 26.01 - 26.56 |
|---|
| 52wk Range: | 17.13 - 29.57 |
|---|
| Volume: | 560,180 |
|---|
| Avg Vol (3m): | 670,702 |
|---|
| Market Cap: | 2.14B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.09 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Investors dump Double B names as rates spike higherat Reuters(Fri, May 17)
- ALERE INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Is Alere's Cash Flow Just For Show?at Motley Fool(Fri, May 17)
- Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred StockPR Newswire(Thu, May 16)
- ALERE INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance SheetEDGAR Online(Thu, May 16)
- Alior Bank Soars to Record Before Joining MSCI Indexat Bloomberg(Thu, May 16)
- Alere downgraded to Hold from Buy at Craig-Hallumat theflyonthewall.com(Tue, May 14)
- Alere Inc. Announces Pricing of Senior Subordinated Notes OfferingPR Newswire(Mon, May 13)
- Alere Inc. Announces Offering of $425 Million of Senior Subordinated NotesPR Newswire(Mon, May 13)
- Alere Earnings Call Insights: Growth Timeframe and Organic Growthat Wall St. Cheat Sheet(Sat, May 11)
- Alere Beats on Both Top and Bottom Linesat Motley Fool(Fri, May 10)
- Alere Inc. Announces Tender Offer and Consent Solicitation for Any and All of its 9.00% Senior Subordinated Notes due 2016PR Newswire(Fri, May 10)
- Finding the Needle of Opportunity in a Haystack of Obamacareat Motley Fool(Fri, May 10)
- Alere Beats Earnings Est, Turns to ProfitZacks(Fri, May 10)
- Alere turns 1Q profit, faces shareholder challengeAP(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | 10.40 |
|---|
| P/S (ttm): | 0.74 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.19 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.48 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.20 |
|---|
Business Summary
Alere Inc. provides diagnostics and services for cardiology, infectious disease, toxicology, and diabetes in the United States and internationally. The company operates in three segments: Professional Diagnostics, Health Information Solutions, and...
View More